Summit Therapeutics Inc (NASDAQ: SMMT) is -2.94% lower on its value in year-to-date trading and has touched a low of $2.10 and a high of $33.89 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SMMT stock was last observed hovering at around $17.36 in the last trading session, with the day’s loss setting it -0.04%.
Currently trading at $17.32, the stock is -11.53% and -13.69% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.44 million and changing -0.23% at the moment leaves the stock -0.67% off its SMA200. SMMT registered 389.27% gain for a year compared to 6-month loss of -6.93%. The firm has a 50-day simple moving average (SMA 50) of $20.0674 and a 200-day simple moving average (SMA200) of $17.43675.
The stock witnessed a -2.59% gain in the last 1 month and extending the period to 3 months gives it a -5.04%, and is -10.21% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.91% over the week and 7.75% over the month.
Summit Therapeutics Inc (SMMT) has around 159 employees, a market worth around $12.78B and $0.00M in sales. Distance from 52-week low is 724.76% and -48.89% from its 52-week high. The company has generated returns on investments over the last 12 months (-56.43%).
The EPS is expected to shrink by -38.33% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Summit Therapeutics Inc (SMMT) Top Institutional Holders
275.0 institutions hold shares in Summit Therapeutics Inc (SMMT), with institutional investors hold 82.56% of the company’s shares. The shares outstanding are 737.63M, and float is at 115.12M with Short Float at 18.43%. Institutions hold 12.91% of the Float.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 23.22 million shares valued at $181.13 million. The investor’s holdings represent 3.2804% of the SMMT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 8.82 million shares valued at $68.78 million to account for 1.2566 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 7.9 million shares representing 1.1158% and valued at over $61.61 million, while FMR LLC holds 1.0687 of the shares totaling 7.57 million with a market value of $59.01 million.
Summit Therapeutics Inc (SMMT) Insider Activity
#####
